University Hospitals Cleveland Medical Center
uhhospitals.orgLive pipeline data from ClinicalTrials.gov, refreshed daily.
Total trials
286
Active
45
Phase 3
23
Total enrollment
372,891
Pipeline matrix
Showing 13 of 13 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Estradiol | — | — | — | — | — | 1 | |
| Bupivacain 0.625%/Fentanyl 2mcg/ml | — | — | — | — | — | 1 | |
| Valtoco Nasal Product | — | — | — | — | — | 1 | |
| Intra-articular | — | — | — | — | — | 1 | |
| Deutetrabenazine Oral | — | — | — | — | — | 1 | |
| IV Magnesium Sulfate | — | — | — | — | — | 1 | |
| Ustekinumab | — | — | — | — | 2 | ||
| Milk thistle | — | — | — | — | — | 1 | |
| Memantine | — | — | — | — | 2 | ||
| Autologous Mesenchymal Stem Cells | — | — | — | — | — | 1 | |
| Dexmedetomidine | — | — | — | — | 2 | ||
| Ropivacaine | — | — | — | — | — | 1 | |
| Iohexol | — | — | — | — | — | 1 |
Next readouts
- 2026-07
- 2026-08-31
- 2026-09-30
- 2026-12-31
- 2026-12-31
- 2027-01-25
- 2027-04-01
- 2027-08-11
- 2027-10-01
- 2028-05
Top conditions
- Bipolar Disorder20
- Sickle Cell Disease8
- Cystic Fibrosis8
- Psoriasis7
- Inflammation5
- HIV Infections5
- Postoperative Pain5
- Diverticulitis4
Frequently asked questions about University Hospitals Cleveland Medical Center
- How many clinical trials does University Hospitals Cleveland Medical Center have on ClinicalTrials.gov?
- University Hospitals Cleveland Medical Center is listed as the lead sponsor on 286 clinical trials in ClinicalTrials.gov, 45 of which are currently active (recruiting, enrolling, or ongoing).
- How many of University Hospitals Cleveland Medical Center's trials are in Phase 3?
- 23 of University Hospitals Cleveland Medical Center's trials are in Phase 3, spread across 13 active drug programs.
- What therapeutic areas does University Hospitals Cleveland Medical Center focus on?
- University Hospitals Cleveland Medical Center's most-studied conditions on ClinicalTrials.gov are Bipolar Disorder, Sickle Cell Disease, Cystic Fibrosis, Psoriasis, Inflammation.
- When are University Hospitals Cleveland Medical Center's next clinical trial readouts?
- University Hospitals Cleveland Medical Center has 10 upcoming primary-completion readouts tracked here; the soonest is “Impact of Mesenchymal Stem Cells in Knee Osteoarthritis”, expected around 2026-07.